PALO ALTO, Calif., March 1, 2017 /PRNewswire/ -- Varian Medical
Systems (NYSE: VAR) today announced that José Baselga,
Physician-in-Chief at Memorial Sloan Kettering Cancer Center (MSK)
and Professor of Medicine at Weill Cornell Medical College, and
Jean-Luc Butel, Senior Adviser to
the McKinsey Healthcare Practice, have been appointed to the Varian
Board of Directors, effective March 1,
2017, to serve until their re-election or their successors
are elected at the next annual meeting of stockholders in 2018.
"I am excited that José Baselga and Jean-Luc Butel have joined the Varian board,"
said R. Andrew Eckert, Chairman of
Varian's Board of Directors. "José brings extensive experience in
the treatment and research of cancer, and Jean-Luc has a proven
successful track record of working for major US healthcare
companies in various global executive leadership positions. Both
are very well qualified to serve on our board."
Dr. Baselga, 57, has served as Physician-in-Chief at MSK and
Professor of Medicine at Weill Cornell Medical College since 2013.
Prior to MSK, Dr. Baselga was the Chief of the Division of
Hematology / Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and
Professor of Medicine at Harvard Medical
School from 2010-2012. He was also the Chairman of
Medical Oncology and Founding Director of the Vall d'Hebron
Institute of Oncology in Barcelona,
Spain from 1996-2010. Dr. Baselga received his medical
degree from Universitat Autonoma de
Barcelona in Barcelona,
Spain and completed residencies at Vall d'Hebron University
Hospital and State University of New York
Health Science Center at Brooklyn. Dr. Baselga is the
most recent Past President of the American Association of Cancer
Research and an elected member of the National Academy of
Medicine. Dr. Baselga is a member of the Board of Directors
of Infinity Pharmaceuticals.
Butel, 60, has served as Senior Adviser to McKinsey Healthcare
Practice since 2015. From 2012 to 2015, Butel served as
Corporate Vice President and President of International at
Baxter. He has held prior
executive management positions at Medtronic, Johnson & Johnson,
and Becton-Dickinson. Butel earned a BA in International Affairs
from The George Washington University
and a MBA in international management from the American
Graduate School of International Management (Thunderbird).
Butel is a member of the Board of Directors of the Singapore
Economic Development Board and Takeda Pharmaceutical Company.
About Varian Medical Systems
Varian Medical Systems
focuses energy on saving lives and is the world's leading
manufacturer of medical devices and software for treating and
managing cancer. Headquartered in Palo
Alto, California, Varian employs approximately 6,400 people
at sites around the world. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Spencer Sias
Varian Medical Systems
+1 (650) 424-5782
spencer.sias@varian.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/jose-baselga-and-jean-luc-butel-appointed-to-board-of-directors-of-varian-medical-systems-300415669.html
SOURCE Varian Medical Systems